02 . 11 .2026
Press release
Galderma announces proposed Board appointments and Chief Financial Officer transition
26 . 10 .2026
Press release
Galderma launches ALASTIN Restorative Eye Complex with TriHex+™, bringing new science-backed innovation to the entire eye area
23 . 10 .2026
Press release
Galderma’s Relfydess™ (relabotulinumtoxinA) receives approval in China for frown lines
22 . 10 .2026
Press release
Galderma delivers net sales of 4.765 B USD in the first nine months, up 25.1% at constant currency year-on-year, and raises full-year net sales guidance
21 . 10 .2026
Press release
AMWC Dubai 2026: Galderma reinforces its Injectable Aesthetics leadership
15 . 10 .2026
Press release
PeDRA 2026: Nemolizumab phase II data show long-term symptom relief for children aged 2 to 11 years with moderate-to-severe atopic dermatitis
14 . 10 .2026
Press release
Galderma signs agreement to acquire ZO Skin Health, strengthening its physician-dispensed skincare offering
13 . 10 .2026
Press release
New Galderma research reveals more than half of women mistake menopause-related skin changes for signs of ageing
